Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice
University of California, San Francisco · Oaklands Hospital
Indexed incrossrefpubmed
Abstract
Recent in vivo and in vitro work suggests that mesenchymal stem cells (MSC) have anti-inflammatory properties. In this study, we tested the effect of administering MSC directly into the airspaces of the lung 4 h after the intrapulmonary administration of Escherichia coli endotoxin (5 mg/kg). MSC increased survival compared with PBS-treated control mice at 48 h (80 vs 42%; p
Citation impact
955
total citations
- FWCI
- 19.31
- Percentile
- 100%
- References
- 38
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- Bronchoalveolar lavage
- Mesenchymal stem cell
- Medicine
- Proinflammatory cytokine
- Lung
- Bone marrow
- In vivo
- Pulmonary edema
No related works found for this paper.